Garway-Heath David

Wang Ziyao, Xue Can Can, Li Yiman, Wu You, Pan Zhe, Li Fan et al.

Global OAG prevalence will nearly triple by 2060, reaching 192.7 million, largely driven by the myopia epidemic. This necessitates myopia prevention and targeted OAG screening, especially in younger populations and high-myopia regions.

Konstantakopoulou Evgenia, Gazzard Gus, Garway-Heath David, Adeleke Mariam, Ambler Gareth, Vickerstaff Victoria et al.

Secondary SLT after 3+ years of drops reduced medication for stable glaucoma/OHT patients and lowered IOP for uncontrolled eyes, but didn't eliminate surgery. This supports SLT as a valuable secondary treatment option.

King Anthony J, Hudson Jemma, Azuara-Blanco Augusto, Burr Jennifer, Kernohan Ashleigh, Homer Tara et al.

This study found that for advanced glaucoma, primary trabeculectomy lowered IOP and prevented progression better than medication, with similar safety, but no significant quality-of-life difference.

Gazzard Gus, Konstantakopoulou Evgenia, Garway-Heath David, Adeleke Mariam, Vickerstaff Victoria, Ambler Gareth et al.

The LiGHT trial showed primary SLT offers better long-term glaucoma control than drops, reducing progression and need for incisional and cataract surgeries over six years, making it a safe, effective first-line option.

Kernohan Ashleigh, Homer Tara, Shabaninejad Hosein, King Anthony J, Hudson Jemma, Fernie Gordon et al.

Studying advanced glaucoma, primary medical management was more cost-effective than surgery at 2 years, suggesting it's the preferred initial approach, though longer-term data is needed.

Wong Damon, Chua Jacqueline, Tan Bingyao, Yao Xinwen, Chong Rachel, Sng Chelvin C A et al.

This study found combining OCT structural and OCTA vascular data better models focal visual field loss in early glaucoma than either alone, suggesting improved early disease evaluation.

King Anthony J, Hudson Jemma, Fernie Gordon, Kernohan Ashleigh, Azuara-Blanco Augusto, Burr Jennifer et al.

For advanced glaucoma, primary trabeculectomy achieved lower eye pressure than medication, with similar quality of life and safety outcomes, suggesting it's a viable initial treatment option.

Wright David M, Konstantakopoulou Evgenia, Montesano Giovanni, Nathwani Neil, Garg Anurag, Garway-Heath David et al.

This study found that initial selective laser trabeculoplasty (SLT) led to less visual field progression in glaucoma/ocular hypertension patients compared to initial medical therapy, suggesting SLT may be a better first-line option.

Garg Anurag, Vickerstaff Victoria, Nathwani Neil, Garway-Heath David, Konstantakopoulou Evgenia, Ambler Gareth et al.

Repeat SLT in medication-naive glaucoma/OHT patients effectively maintains IOP control for at least 18 months, with similar duration of effect to initial treatment, offering a valuable retreatment option.

Garg Anurag, Vickerstaff Victoria, Nathwani Neil, Garway-Heath David, Konstantakopoulou Evgenia, Ambler Gareth et al.

Primary SLT for OAG/OHT showed comparable early IOP lowering to medication, achieving drop-free disease control in ~75% of eyes at 36 months, supporting its effectiveness and safety.

Gazzard Gus, Konstantakopoulou Evgenia, Garway-Heath David, Garg Anurag, Vickerstaff Victoria, Hunter Rachael et al.

This study found SLT is as effective as eye drops for first-line glaucoma/ocular hypertension treatment, with 74% needing no drops at 3 years and being more cost-effective, supporting its routine use.

Yousefi Siamak, Sakai Hiroshi, Murata Hiroshi, Fujino Yuri, Matsuura Masato, Garway-Heath David et al.

This study found POAG eyes lose superior visual field faster than inferior, unlike PACG eyes, suggesting different progression patterns for these glaucoma types.

Yousefi Siamak, Sakai Hiroshi, Murata Hiroshi, Fujino Yuri, Garway-Heath David, Weinreb Robert et al.

This study found primary open-angle glaucoma causes more pronounced superior visual field loss than primary angle-closure glaucoma, which can aid in differentiating these conditions clinically.

Patel Dipesh E, Cumberland Phillippa M, Walters Bronwen C, Russell-Eggitt Isabelle, Brookes John, Papadopoulos Maria et al.

This study compared visual field tests in children with glaucoma, finding simple static perimetry works well for younger children, while adding kinetic testing helps older children with severe vision loss.

Gazzard Gus, Konstantakopoulou Evgenia, Garway-Heath David, Barton Keith, Wormald Richard, Morris Stephen et al.

The LiGHT trial is studying if initial selective laser trabeculoplasty (SLT) is better than eye drops for primary open-angle glaucoma/ocular hypertension, focusing on quality of life and cost-effectiveness.

Patel Dipesh E, Viswanathan Ananth C, Garway-Heath David, Cumberland Phillippa M, Walters Bronwen C, Russell-Eggitt Isabelle et al.

This study developed KPRM, a new objective measure for kinetic perimetry reliability in children. It quantifies test variability, was feasible in all children, and correlated with subjective assessments, improving accuracy for pediatric visual field interpretation.

Banister Katie, Boachie Charles, Bourne Rupert, Cook Jonathan, Burr Jennifer M, Ramsay Craig et al.

This study compared four automated imaging tests for glaucoma detection, finding they aid diagnosis but can miss severe cases, indicating they supplement rather than replace clinical assessment.

Ratnarajan Gokulan, Hirn Cornelia, Normando Eduardo, Poli Muriel, Scott Andrew, Munoz Marcos et al.

Realini Tony, Zangwill Linda M, Flanagan John G, Garway-Heath David, Patella Vincent M, Johnson Chris A et al.

Glaucoma imaging device accuracy is limited by varied normative databases; standardizing database development could improve diagnostic reliability and inter-device comparability.

Elsheikh Ahmed, Gunvant Pinakin, Jones Stephen W, Pye David, Garway-Heath David

This study found Elsheikh and Chihara equations significantly improved Goldmann Tonometry accuracy on donor corneas, suggesting clinical utility for more precise IOP estimation.

Kong Yu Xiang G, Coote Michael A, O'Neill Evelyn C, Gurria Lulu U, Xie Jing, Garway-Heath David et al.

This study developed an online tool to assess optic disc examination skills, finding glaucoma subspecialists had better agreement on glaucoma likelihood and disc features than trainees, highlighting areas for skill improvement.

Giangiacomo Annette, Garway-Heath David, Caprioli Joseph

This review highlights new visual field and structural imaging technologies (OCT, etc.) that enhance glaucoma progression diagnosis, offering more accurate patient management.

Kamal Deborah, Garway-Heath David, Ruben Simon, O'Sullivan Fiona, Bunce Catey, Viswanathan Anath et al.

This study found betaxolol lowered IOP in ocular hypertension but did not significantly prevent conversion to glaucoma compared to placebo, suggesting limited clinical benefit for prevention.